07-43

Biomarkers for Early Pancreatic Cancer Detection and Treatment

Patent No. US8609437B2; Summary

  Anthony Yeung 

Inna Khartchenko

 256-JT

Novel Diagnostic and Prognostic Marker for Malignant Mesothelioma 

Patent No. US10344333B2; Summary

 Joseph Testa

Tatiana Venkova

 305-MC

Estrogen Metabolite Levels and CYP1B1 Polymorphisms in Lung Cancer Diagnosis, Prognosis, and Risk Assessment

Published Application No.US20140363406A1

 Margie Clapper

Natalia Shalginskikh

 312-GE

Novel Diagnostic Method for Predisposition to Colorectal Cancer

Patent No. US9157124B2; Summary

 Greg Enders

Inna Khartchenko

 364-EP

Novel Screening Biomarkers for Muscle Invasive Bladder Cancer Response to Chemotherapy

Published Application No.US20150184251A1; Summary

 Elizabeth Plimack

Natalia Shalginskikh

 394-EG

Novel Biomarkers for Prognosis and Diagnosis of Prostate Cancer

Published Application No.WO2017049023A1; Summary

Erica Golemis

Tatiana Venkova

 396-EC

Novel Biomarker For Risk Assessment And Treatment Evaluation For Cancers With Fibrosis

Published Application No.WO2018005355; Summary

Edna Cukierman 

Natalia Shalginskikh

 426-SA

Methods For Diagnosis And Treatment Of Patients Having Solid Tumors

Published Application No.WO2018152154A1; Summary

Sanjeevani Arora

Tatiana Venkova

431-WE

High EGFR Somatic Mutation Frequency Targeting the TK Domain in Colorectal Cancer Patients with Microsatellite Instability (MSI)

Published Application No.WO2018157032A1; Summary

Wafik El-Deiry

Tatiana Venkova

 443-JFB

Novel Cancer Prognostic based on MHC-I Genotype and Presentability

Published Application No.WO2019005764A1; Summary

Joan Font-Burgada

Tatiana Venkova

461-PA

 Urinary DNA Detection for Monitoring of Urothelial Cancer

Published Application No.WO2019222325A1;  Summary

Philip Abbosh

Natalia Shalginskikh

522-MC

Estrogen Metabolite Levels and EGFR Mutations in Lung Cancer Risk Stratification and Treatment

Patent pending

Margie Clapper

Natalia Shalginskikh